European Archives - Page 994 of 1112 - European Medical Journal

American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) 2015 Meeting Highlights: New Data on Canakinumab

nterleukin (IL)-1 is a messenger for the regulation of inflammatory responses, but it can be harmful when in excess, such as in the inflammation observed…

Treating Active HIDS with Canakinumab

The efficacy and safety of canakinumab in active hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS) and the implications of the results for the future treatment of patients with the condition.

Pathophysiology and Treatment of HIDS

At the American College of Rheumatology Annual Meeting, topic of interest is the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)

Canakinumab in the treatment of tumour necrosis factor receptor-associated periodic syndrome (TRAPS)

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…

Treatment Strategies for TRAPS

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen Lachmann…

Treatments for Patients with CAPS

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Jasmin Kuemmerle…

EMJ

Structure of Coronavirus Defence Offers Clues to Treatment

DECIPHERING the structure of a key protein in the coronavirus HKU1, a member of a family of deadly viruses, has provided a promising avenue for…

EMJ

First 3D Printed ‘Sneezometer’ Opens Doors to Diagnosis

PIONEERING use of 3D printing technology has enabled the development of simple, non-intrusive, and cost-effective spirometry for the diagnosis of…

EMJ

EULAR Crowdsources Inspirational Stories to Educate the World about Rheumatic and Musculoskeletal Diseases

Sofia, Bulgaria (15 April 2016): EULAR and the Standing Committee of PARE (People with Arthritis/Rheumatism) has launched ‘The Future In Your Hands’…

EMJ

UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy

LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…